TCM Group A/S (CPH:TCM)
67.20
-0.20 (-0.30%)
May 8, 2026, 4:59 PM CET
TCM Group Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,279 | 1,204 | 1,084 | 1,146 | 1,108 | |
Revenue Growth (YoY) | 6.26% | 11.04% | -5.40% | 3.41% | 8.17% |
Cost of Revenue | 988.72 | 948.38 | 868.33 | 915.4 | 853.67 |
Gross Profit | 290.47 | 255.41 | 215.8 | 230.65 | 254.6 |
Selling, General & Admin | 206.73 | 184.49 | 166.6 | 131.09 | 116.85 |
Other Operating Expenses | -10.1 | -9.89 | -5.41 | -3.83 | - |
Operating Expenses | 196.64 | 174.6 | 161.19 | 127.26 | 116.85 |
Operating Income | 93.84 | 80.81 | 54.61 | 103.39 | 137.76 |
Interest Expense | -21.25 | -24.16 | -20.47 | -9.22 | -3.6 |
Interest & Investment Income | 0.94 | 1.19 | 0.44 | 0.44 | 0.34 |
Earnings From Equity Investments | -1.35 | 5.73 | 2.19 | - | 0.55 |
Currency Exchange Gain (Loss) | 0.2 | -2.36 | -0.2 | - | - |
Other Non Operating Income (Expenses) | -0.94 | -1.27 | -0.67 | 1.26 | - |
EBT Excluding Unusual Items | 71.45 | 59.94 | 35.91 | 95.88 | 135.05 |
Merger & Restructuring Charges | -2.31 | - | -7.9 | -4.66 | -1.3 |
Asset Writedown | - | - | -1.91 | - | - |
Other Unusual Items | 24.76 | 9.5 | 1 | -1.82 | 1.99 |
Pretax Income | 93.9 | 69.44 | 27.09 | 89.4 | 135.74 |
Income Tax Expense | 16.13 | 11.77 | 5.57 | 18.91 | 25.03 |
Net Income | 77.77 | 57.68 | 21.52 | 70.49 | 110.71 |
Net Income to Common | 77.77 | 57.68 | 21.52 | 70.49 | 110.71 |
Net Income Growth | 34.84% | 167.98% | -69.47% | -36.33% | 8.28% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 9 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 9 | 10 |
Shares Change (YoY) | -0.78% | 7.09% | 7.69% | -5.31% | -4.07% |
EPS (Basic) | 7.51 | 5.52 | 2.20 | 7.77 | 11.55 |
EPS (Diluted) | 7.48 | 5.51 | 2.20 | 7.76 | 11.54 |
EPS Growth | 35.75% | 150.46% | -71.65% | -32.76% | 12.92% |
Free Cash Flow | 70.94 | 82.5 | 59.65 | 49.58 | 44.64 |
Free Cash Flow Per Share | 6.83 | 7.88 | 6.10 | 5.46 | 4.65 |
Dividend Per Share | 4.500 | 3.000 | - | - | 6.000 |
Dividend Growth | 50.00% | - | - | - | 9.09% |
Gross Margin | 22.71% | 21.22% | 19.91% | 20.13% | 22.97% |
Operating Margin | 7.33% | 6.71% | 5.04% | 9.02% | 12.43% |
Profit Margin | 6.08% | 4.79% | 1.98% | 6.15% | 9.99% |
Free Cash Flow Margin | 5.54% | 6.85% | 5.50% | 4.33% | 4.03% |
EBITDA | 123.1 | 109.94 | 80.69 | 116.59 | 149.41 |
EBITDA Margin | 9.62% | 9.13% | 7.44% | 10.17% | 13.48% |
D&A For EBITDA | 29.27 | 29.13 | 26.08 | 13.2 | 11.66 |
EBIT | 93.84 | 80.81 | 54.61 | 103.39 | 137.76 |
EBIT Margin | 7.33% | 6.71% | 5.04% | 9.02% | 12.43% |
Effective Tax Rate | 17.17% | 16.95% | 20.56% | 21.15% | 18.44% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.